An in-house scintigraphic study confirms the delayed release that is possible with DRcaps.
Ingredient suppliers often tout the delayed released of ingredients with special coatings, but softgels and capsules provider Capsugel (Morristown, NJ) has actual proof with its delayed release capsules.
In a newly completed scintigraphic study, researchers tracked the in vivo release of ingredients contained within Capsugel DRcaps capsules. By radiolabeling the active ingredients, they could detect precisely when the ingredients were released from the capsules. Bypassing early activation of human stomach acids, the capsules began to release their ingredients at a mean time of 52 minutes after ingestion, with complete release recorded at a mean 72 minutes. “That is 45 minutes later than an immediate-release capsule, and [it] means that the contents of the capsules would often be released in the intestines-where probiotics and enzyme ingredients are most effective,” says Keith Hutchison, PhD, vice president of R&D at Capsugel.
DRcaps are vegetarian capsules made from acid-resistant hydroxypropyl methylcellulose (HPMC). Their ability to slow the release of active ingredients is attributed to what the company calls their “unique polymer properties,” which slow the capsule’s opening without the help of chemical solvents.
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.